載入...
Conservative management of nivolumab-induced pericardial effusion: a case report and review of literature
Abstract Background Nivolumab is an immune checkpoint inhibitor targeting programmed death-1 protein and has been approved for the treatment of multiple advanced malignancies. Adverse effects of immune checkpoint inhibitors are distinct from conventional cytotoxic chemotherapy and can be life-threat...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BMC
2018-05-01
|
| 叢編: | Experimental Hematology & Oncology |
| 主題: | |
| 在線閱讀: | http://link.springer.com/article/10.1186/s40164-018-0104-y |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|